Literature DB >> 20193969

Heart failure etiology impacts survival of patients with heart failure.

Redi Pecini1, Daniel Vega Møller2, Christian Torp-Pedersen3, Christian Hassager2, Lars Køber2.   

Abstract

BACKGROUND: The impact of heart failure (HF) etiology on prognosis of HF is not well known.
METHODS: 3078 patients (median age 75 years, 61% male) hospitalized with HF were studied. Patients were classified into six etiology groups: hypertension (HTN, 13.9%), ischemic heart disease (IHD, 42.4%), valvular disease (VHD, 9.5%), dilated cardiomyopathy (DCM, 7.9%), other (11.5%), and unknown etiology (14.8%). Patients with normal left ventricular ejection fraction (LVEF) were also included. Follow-up was up to 5 years.
RESULTS: In multivariable analysis, with HTN as the reference, VHD showed the highest risk, HR 1.71 (CI: 1.3-2.2, p<0.0001), followed by DCM, HR 1.66 (CI: 1.2-2.3, p=0.002), IHD, HR 1.4 (CI: 1.1-1.7, p=0.001), and unknown etiology, HR 1.4 (CI: 1.1-1.7, p=0.007). For HF of IHD mortality risk was greater for patients with LVEF<30% (HR 2.1, CI: 1.7-2.7, p<0.0001) than for patients with LVEF ≥ 30% (HR 1.3, CI: 1.0-1.5, p=0.03), compared to the reference (p-value for interaction<0.001).
CONCLUSION: HF due to VHD, DCM and IHD carry a worse prognosis than that of HTN. For the IHD the risk increases progressively with lower values of LVEF.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20193969     DOI: 10.1016/j.ijcard.2010.01.011

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  15 in total

Review 1.  Is extensive atrial fibrosis in the setting of heart failure associated with a reduced atrial fibrillation burden?

Authors:  Alexander Burashnikov; Charles Antzelevitch
Journal:  Pacing Clin Electrophysiol       Date:  2018-09-09       Impact factor: 1.976

2.  The relationship between aminoterminal propeptide of type III procollagen and heart rate variability parameters in heart failure patients: a potential serum marker to evaluate cardiac autonomic control and sudden cardiac death.

Authors:  Yen-Hung Lin; Chen Lin; Men-Tzung Lo; Hung-Ju Lin; Yen-Wen Wu; Ron-Bin Hsu; Chia-Lun Chao; Hsiu-Ching Hsu; Pa-Chun Wang; Vin-Cent Wu; Shoei-Shen Wang; Chi-Ming Lee; Kuo-Liong Chien; Yi-Lwun Ho; Ming-Fong Chen; Chung-Kang Peng
Journal:  Clin Chem Lab Med       Date:  2010-09-17       Impact factor: 3.694

3.  Accurate Classification of Cardiomyopathy Diagnosis by Chromatin Accessibility.

Authors:  Samadrita Bhattacharyya; Jialei Duan; Ryan J Vela; Minoti Bhakta; Pietro Bajona; Pradeep P A Mammen; Gary C Hon; Nikhil V Munshi
Journal:  Circulation       Date:  2022-09-12       Impact factor: 39.918

4.  Hereditary hemochromatosis (HFE) genotypes in heart failure: relation to etiology and prognosis.

Authors:  Daniel V Møller; Redi Pecini; Finn Gustafsson; Christian Hassager; Paula Hedley; Cathrine Jespersgaard; Christian Torp-Pedersen; Michael Christiansen; Lars V Køber
Journal:  BMC Med Genet       Date:  2010-07-29       Impact factor: 2.103

5.  Insights from Second-Line Treatments for Idiopathic Dilated Cardiomyopathy.

Authors:  Marco Luciani; Federica Del Monte
Journal:  J Cardiovasc Dev Dis       Date:  2017-08-23

6.  Differences in Clinical Presentation and Findings between Idiopathic Dilated and Ischaemic Cardiomyopathy in an Unselected Population of Heart Failure Patients.

Authors:  Lilian Mantziari; Antonis Ziakas; Ioannis Ventoulis; Vasileios Kamperidis; Leonidas Lilis; Niki Katsiki; Savvato Karavasiliadou; Konstantinos Kiraklidis; Christodoulos Pliakos; Konstantinos Gemitzis; Haralambos Karvounis; Ioannis H Styliadis
Journal:  Open Cardiovasc Med J       Date:  2012-09-07

7.  Prognostic Factors for Survival at 6-Month Follow-up of Hospitalized Patients with Decompensated Congestive Heart Failure.

Authors:  Mostafa Cheraghi; Masoumeh Sadeghi; Nizal Sarrafzadegan; Ali Pourmoghadas; Mohammad Arash Ramezani
Journal:  ARYA Atheroscler       Date:  2010

8.  Clinical characteristics and long-term prognosis of ischemic and non-ischemic cardiomyopathy.

Authors:  Zhi-Hua Zhang; Fan-Qi Meng; Xiao-Feng Hou; Zhi-Yong Qian; Yao Wang; Yuan-Hao Qiu; Zhe-Yu Jiang; An-Jie Du; Chao-Tong Qin; Jian-Gang Zou
Journal:  Indian Heart J       Date:  2020-04-28

9.  Heart failure in dilated non-ischaemic cardiomyopathy.

Authors:  Petar M Seferović; Marija M Polovina; Andrew J S Coats
Journal:  Eur Heart J Suppl       Date:  2019-12-31       Impact factor: 1.803

10.  Mid-wall striae fibrosis predicts heart failure admission, composite heart failure events, and life-threatening arrhythmias in dilated cardiomyopathy.

Authors:  Yanish Purmah; Aidan Cornhill; Lucy Y Lei; Steven Dykstra; Yoko Mikami; Alessandro Satriano; Dina Labib; Jacqueline Flewitt; Sandra Rivest; Rosa Sandonato; Michelle Seib; Andrew G Howarth; Carmen P Lydell; Bobak Heydari; Naeem Merchant; Michael Bristow; Louis Kolman; Nowell M Fine; James A White
Journal:  Sci Rep       Date:  2022-02-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.